• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于扩散加权成像的肝纤维化评估:以脾脏作为参考器官进行肝脏表观扩散系数标准化的价值

Liver Fibrosis Assessment with Diffusion-Weighted Imaging: Value of Liver Apparent Diffusion Coefficient Normalization Using the Spleen as a Reference Organ.

作者信息

Shin Min Ki, Song Ji Soo, Hwang Seung Bae, Hwang Hong Pil, Kim Young Jun, Moon Woo Sung

机构信息

Department of Radiology, Chonbuk National University Medical School and Hospital, Jeonju 54907, Korea.

Research Institute of Clinical Medicine of Chonbuk National University, Jeonju 54907, Korea.

出版信息

Diagnostics (Basel). 2019 Aug 28;9(3):107. doi: 10.3390/diagnostics9030107.

DOI:10.3390/diagnostics9030107
PMID:31466404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6787628/
Abstract

Liver fibrosis staging is of great clinical importance because it is used to assess the severity of the underlying chronic liver disease. Among various imaging-based methods, apparent diffusion coefficient (ADC) measurement using diffusion-weighted imaging (DWI) has the potential to be used as an imaging biomarker for liver fibrosis assessment. In this study, we investigated the usefulness of liver ADC normalization using the spleen as a reference organ in liver fibrosis staging with 66 patients who underwent liver magnetic resonance imaging (MRI), transient elastography (TE), and surgical resection of a hepatic mass. ADC values of the liver (ADC) and spleen were analyzed, and the spleen was used for ADC normalization (nADC). ADC showed a weak negative correlation with TE ( = -0.246; = 0.047) and fibrosis stage ( = -0.269; = 0.029), while n ADC showed a moderate negative correlation with TE ( = -0.504; < 0.001) and fibrosis stage ( = -0.579; < 0.001). AUC values for nADC (0.777-0.875) were higher than those for ADC for each stage of fibrosis (0.596-0.713, = 0.037-0.157). AUC values for TE (0.726-0.884) and nADC were not statistically different. In conclusion, normalized liver ADC can be useful in diagnosing liver fibrosis stage in patients with variable DWI acquisitions.

摘要

肝纤维化分期具有重要的临床意义,因为它用于评估潜在慢性肝病的严重程度。在各种基于成像的方法中,使用扩散加权成像(DWI)测量表观扩散系数(ADC)有潜力作为肝纤维化评估的成像生物标志物。在本研究中,我们对66例接受肝脏磁共振成像(MRI)、瞬时弹性成像(TE)和肝脏肿块手术切除的患者,研究了以脾脏作为参考器官进行肝脏ADC标准化在肝纤维化分期中的作用。分析了肝脏(ADC)和脾脏的ADC值,并将脾脏用于ADC标准化(nADC)。ADC与TE呈弱负相关(r = -0.246;P = 0.047),与纤维化分期呈弱负相关(r = -0.269;P = 0.029),而nADC与TE呈中度负相关(r = -0.504;P < 0.001),与纤维化分期呈中度负相关(r = -0.579;P < 0.001)。各纤维化阶段nADC的曲线下面积(AUC)值(0.777 - 0.875)高于ADC的AUC值(0.596 - 0.713,P = 0.037 - 0.157)。TE的AUC值(0.726 - 0.884)与nADC无统计学差异。总之,标准化的肝脏ADC在诊断不同DWI采集患者的肝纤维化分期中可能有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c6/6787628/340b6620110f/diagnostics-09-00107-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c6/6787628/65d6a6ca7b9e/diagnostics-09-00107-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c6/6787628/a82599a22b25/diagnostics-09-00107-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c6/6787628/f51fd80dbbfa/diagnostics-09-00107-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c6/6787628/340b6620110f/diagnostics-09-00107-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c6/6787628/65d6a6ca7b9e/diagnostics-09-00107-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c6/6787628/a82599a22b25/diagnostics-09-00107-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c6/6787628/f51fd80dbbfa/diagnostics-09-00107-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c6/6787628/340b6620110f/diagnostics-09-00107-g004.jpg

相似文献

1
Liver Fibrosis Assessment with Diffusion-Weighted Imaging: Value of Liver Apparent Diffusion Coefficient Normalization Using the Spleen as a Reference Organ.基于扩散加权成像的肝纤维化评估:以脾脏作为参考器官进行肝脏表观扩散系数标准化的价值
Diagnostics (Basel). 2019 Aug 28;9(3):107. doi: 10.3390/diagnostics9030107.
2
Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ.弥散加权成像诊断肝纤维化和肝硬化:应用脾脏作为参照器官的标准化表观弥散系数的价值。
AJR Am J Roentgenol. 2010 Sep;195(3):671-6. doi: 10.2214/AJR.09.3448.
3
Association between liver diffusion-weighted imaging apparent diffusion coefficient values and other measures of liver disease in pediatric autoimmune liver disease patients.儿童自身免疫性肝病患者肝脏弥散加权成像表观弥散系数值与其他肝脏疾病指标的相关性。
Abdom Radiol (NY). 2021 Jan;46(1):197-204. doi: 10.1007/s00261-020-02595-3.
4
Diffusion-weighted magnetic resonance imaging for the assessment of liver fibrosis in chronic viral hepatitis.弥散加权磁共振成像在慢性病毒性肝炎肝纤维化评估中的应用。
PLoS One. 2021 Mar 4;16(3):e0248024. doi: 10.1371/journal.pone.0248024. eCollection 2021.
5
Spleen magnetic resonance diffusion-weighted imaging for quantitative staging hepatic fibrosis in miniature pigs: An initial study.脾脏磁共振弥散加权成像在小型猪肝纤维化定量分期中的初步研究。
Hepatol Res. 2013 Nov;43(11):1231-40. doi: 10.1111/hepr.12076. Epub 2013 Feb 20.
6
Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.磁共振弥散加权成像与钆塞酸二钠增强磁共振动态成像对原发性硬化性胆管炎患者肝纤维化的检测及分期的前瞻性比较。
Eur Radiol. 2019 Feb;29(2):818-828. doi: 10.1007/s00330-018-5614-9. Epub 2018 Jul 16.
7
Apparent diffusion coefficient normalization of normal liver: Will it improve the reproducibility of diffusion-weighted imaging at different MR scanners as a new biomarker?正常肝脏的表观扩散系数标准化:作为一种新的生物标志物,它能否提高不同磁共振扫描仪上扩散加权成像的可重复性?
Medicine (Baltimore). 2017 Jan;96(3):e5910. doi: 10.1097/MD.0000000000005910.
8
Transient elastography and diffusion-weighted magnetic resonance imaging for assessment of liver fibrosis in children with chronic hepatitis C.瞬时弹性成像和扩散加权磁共振成像用于评估慢性丙型肝炎儿童的肝纤维化
World J Virol. 2024 Sep 25;13(3):96369. doi: 10.5501/wjv.v13.i3.96369.
9
Relative ADC measurement for liver fibrosis diagnosis in chronic hepatitis B using spleen/renal cortex as the reference organs at 3 T.使用脾脏/肾皮质作为参考器官在 3T 下对慢性乙型肝炎肝纤维化进行相对 ADC 测量。
Clin Radiol. 2014 Jun;69(6):581-8. doi: 10.1016/j.crad.2014.01.004. Epub 2014 Feb 26.
10
Noninvasive evaluation of liver fibrosis: comparison of the stretched exponential diffusion-weighted model to other diffusion-weighted MRI models and transient elastography.无创性肝纤维化评估:拉伸指数扩散加权模型与其他扩散加权 MRI 模型和瞬时弹性成像的比较。
Eur Radiol. 2021 Jul;31(7):4813-4823. doi: 10.1007/s00330-020-07600-3. Epub 2021 Jan 13.

引用本文的文献

1
Quantitative MRI of diffuse liver diseases: techniques and tissue-mimicking phantoms.弥散性肝脏疾病的定量 MRI:技术和组织模拟体模。
MAGMA. 2023 Aug;36(4):529-551. doi: 10.1007/s10334-022-01053-z. Epub 2022 Dec 14.
2
Assessment of hepatic fibrosis and inflammation with look-locker T1 mapping and magnetic resonance elastography with histopathology as reference standard.应用 Look-Locker T1 mapping 和磁共振弹性成像评估肝纤维化和炎症,并以组织病理学为参考标准。
Abdom Radiol (NY). 2022 Nov;47(11):3746-3757. doi: 10.1007/s00261-022-03647-6. Epub 2022 Aug 29.
3
The Efficiency of Fractional Anisotropy, Apparent Diffusion Coefficient, and Contrast Enhancement Index in Liver Fibrosis Staging.

本文引用的文献

1
Diffusion-weighted MR imaging of upper abdominal organs at different time points: Apparent diffusion coefficient normalization using a reference organ.不同时间点上腹部器官的扩散加权磁共振成像:使用参考器官进行表观扩散系数标准化
J Magn Reson Imaging. 2017 May;45(5):1494-1501. doi: 10.1002/jmri.25456. Epub 2016 Sep 13.
2
Critical comparison of elastography methods to assess chronic liver disease.弹性成像方法评估慢性肝病的对比研究。
Nat Rev Gastroenterol Hepatol. 2016 Jul;13(7):402-11. doi: 10.1038/nrgastro.2016.86. Epub 2016 Jun 8.
3
Noninvasive Assessment of Liver Fibrosis.
分数各向异性、表观扩散系数和对比增强指数在肝纤维化分期中的效能
Sisli Etfal Hastan Tip Bul. 2022 Mar 28;56(1):113-118. doi: 10.14744/SEMB.2021.33396. eCollection 2022.
4
Fat- and iron-corrected ADC to assess liver fibrosis in patients with chronic hepatitis B.脂肪和铁校正 ADC 评估慢性乙型肝炎患者的肝纤维化。
Diagn Interv Radiol. 2022 Jan;28(1):5-11. doi: 10.5152/dir.2021.21471.
5
Quantitative diffusion MRI of the abdomen and pelvis.腹部和盆腔的定量扩散 MRI。
Med Phys. 2022 Apr;49(4):2774-2793. doi: 10.1002/mp.15246. Epub 2021 Oct 8.
6
Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and H-MR spectroscopy compared with histology (subgroup in the RAXO trial).结直肠癌肝转移新辅助或转化治疗的疗效评价:前瞻性多中心随访研究,采用 MRI、扩散加权成像和 H-MR 光谱与组织学比较(RAXO 试验的亚组)。
ESMO Open. 2021 Aug;6(4):100208. doi: 10.1016/j.esmoop.2021.100208. Epub 2021 Jul 26.
7
Repeatability of Apparent Diffusion Coefficient at 3.0 Tesla in Normal Pancreas.3.0特斯拉下正常胰腺表观扩散系数的可重复性
Cureus. 2021 Jun 18;13(6):e15734. doi: 10.7759/cureus.15734. eCollection 2021 Jun.
8
Diffusion-weighted MRI and FLAIR sequence for differentiation of hydatid cysts and simple cysts in the liver.磁共振扩散加权成像及液体衰减反转恢复序列用于肝脏包虫囊肿与单纯囊肿的鉴别诊断
Eur J Radiol Open. 2021 May 31;8:100355. doi: 10.1016/j.ejro.2021.100355. eCollection 2021.
肝纤维化的无创评估
Dig Dis. 2015;33(4):498-503. doi: 10.1159/000374097. Epub 2015 Jul 6.
4
Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B.在中国慢性乙型肝炎患者队列中,瞬时弹性成像与血清标志物用于预测肝纤维化的比较
J Gastroenterol Hepatol. 2015 Apr;30(4):756-62. doi: 10.1111/jgh.12840.
5
Assessing liver fibrosis: comparison of arterial enhancement fraction and diffusion-weighted imaging.评估肝纤维化:动脉强化分数与扩散加权成像的比较
J Magn Reson Imaging. 2014 Nov;40(5):1137-46. doi: 10.1002/jmri.24472. Epub 2013 Nov 25.
6
Agreement and reproducibility of apparent diffusion coefficient measurements of dual-b-value and multi-b-value diffusion-weighted magnetic resonance imaging at 1.5 Tesla in phantom and in soft tissues of the abdomen.1.5特斯拉下双b值和多b值扩散加权磁共振成像在体模及腹部软组织中表观扩散系数测量的一致性和可重复性
J Comput Assist Tomogr. 2013 Jan-Feb;37(1):46-51. doi: 10.1097/RCT.0b013e3182720e07.
7
Effects of gadoxetic acid on quantitative diffusion-weighted imaging of the liver.钆塞酸对肝脏定量扩散加权成像的影响。
J Magn Reson Imaging. 2013 Aug;38(2):365-70. doi: 10.1002/jmri.23978. Epub 2012 Dec 13.
8
Diffusion-weighted magnetic resonance imaging for staging liver fibrosis is less reliable in the presence of fat and iron.弥散加权磁共振成像在存在脂肪和铁的情况下对肝纤维化分期的可靠性较低。
Eur Radiol. 2013 May;23(5):1281-7. doi: 10.1007/s00330-012-2700-2. Epub 2012 Nov 9.
9
Diagnostic performance of conventional diffusion weighted imaging and diffusion tensor imaging for the liver fibrosis and inflammation.常规弥散加权成像和弥散张量成像对肝纤维化和炎症的诊断性能。
Eur J Radiol. 2013 Feb;82(2):203-7. doi: 10.1016/j.ejrad.2012.09.009. Epub 2012 Nov 2.
10
Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging.慢性肝炎和纤维化的评估:磁共振弹性成像与弥散加权成像的比较。
AJR Am J Roentgenol. 2011 Mar;196(3):553-61. doi: 10.2214/AJR.10.4580.